Join
Live feed
·
PRReleasevia Quantisnow
Clarus Therapeutics Holdings Inc. logo

Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

ByQuantisnow·Wall Street's wire, on your screen.
CRXT· Clarus Therapeutics Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRXT (Clarus Therapeutics Holdings Inc.) and more on Quantisnow.